Genetics/Genomics

An enzyme that helps the novel coronavirus (COVID-19) infect the body also plays a role in inflammation and patient outcomes in inflammatory bowel

Sex, age, and severity of disease may be useful in identifying novel coronavirus (COVID-19) survivors who are likely to have high levels of

Novel coronavirus (COVID-19) antibodies can last at least three months after a person becomes infected with SARS-CoV-2, the virus that causes

Events at birth may affect the microbes living in a baby's gut during the first few months of life, leading to a higher risk of childhood obesity and

People with blood type O may have a lower risk of novel coronavirus (COVID-19) infection and reduced likelihood of severe outcomes, including organ

Using dried blood spot samples is an accurate alternative to venous blood in detecting SARS-CoV-2, the virus that causes the novel coronavirus

Patients with human immunodeficiency virus (HIV) are susceptible to the novel coronavirus (COVID-19), and certain factors increase the risk of

A proportion of the most severe novel coronavirus (COVID-19) cases can be explained by genetic defects in the patients' immune system, according to a